Key statistics
On Friday, Cytodyn Inc (CYDY:QBB) closed at 0.315, -36.30% below its 52-week high of 0.4945, set on Feb 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.316 |
---|---|
High | 0.32 |
Low | 0.291 |
Bid | -- |
Offer | -- |
Previous close | 0.3182 |
Average volume | 1.82m |
---|---|
Shares outstanding | 1.23bn |
Free float | 1.21bn |
P/E (TTM) | -- |
Market cap | 388.22m USD |
EPS (TTM) | -0.0096 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 20:59 BST.
More ▼
- CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab
- CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
- CytoDyn Releases ESMO Breast Cancer Meeting Poster
- CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
- CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
- CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany
- March 2025 Letter to Shareholders
- CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab
- CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
- December 2024 Letter to Shareholders
More ▼